TC BioPharm (Holdings) (TC BioPharm (Holdings)) Change In Payables And Accrued Expense : $-0.11 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) Change In Payables And Accrued Expense?

TC BioPharm (Holdings)'s Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was $0.03 Mil. It means TC BioPharm (Holdings)'s Accounts Payable & Accrued Expense increased by $0.03 Mil from Dec. 2023 to Mar. 2024 .

TC BioPharm (Holdings)'s Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $2.88 Mil. It means TC BioPharm (Holdings)'s Accounts Payable & Accrued Expense increased by $2.88 Mil from Dec. 2022 to Dec. 2023 .

TC BioPharm (Holdings) Change In Payables And Accrued Expense Historical Data

The historical data trend for TC BioPharm (Holdings)'s Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) Change In Payables And Accrued Expense Chart

TC BioPharm (Holdings) Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

-0.06

0.44

3.11

-2.37

2.88

TC BioPharm (Holdings) Quarterly Data
	Dec19	Sep20	Dec20	Jun21	Sep21	Dec21	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial							-	0.54	-0.14	-	0.03

TC BioPharm (Holdings) Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11 Mil.

TC BioPharm (Holdings) Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

TC BioPharm (Holdings) (TC BioPharm (Holdings)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (NAS:TCBP) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

T0U:Germany

Address

Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR

Website

https://www.tcbiopharm.com

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Executives

Renaissance Capital Partners Ltd	10 percent owner	42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD